Latest News

Back to resources

Displaying 57 - 64 of 71

R&D
Four major developments in life science R&D to look out for in 2023
As arguably the most pivotal stage in the product and pharmaceutical development cycle, it’s...

By SEC Newsroom October 18th, 2022
Employers
Why a wave of biotechs are setting up in Watertown, Massachusetts
A little further downriver from Boston's central life sciences hub sits the city of Watertow...

By Jacob Perrett October 11th, 2022
Candidates
Feeling stagnant in your QA role? Here’s why you should consider a freelance career
Most people start their quality assurance career in a permanent position. Traditional attitu...

By SEC Newsroom September 27th, 2022
Candidates
6 Tips for entry-level recruitment roles: How to stand out when applying
On average, companies will receive over 80 applications per job vacancy, with some top emplo...

By SEC Newsroom September 13th, 2022
R&D
Four Massachusetts-based Cell and Gene Therapy start-ups that are taking 2022 by storm
The east coast of America is seeing a boom in the number of cell and gene therapy (CGT) star...

By Jacob Perrett September 6th, 2022
Commercial
An insight into the challenges of cell and gene therapy commercialisation
Reaching the market with cell and gene therapies (CGTs) is no easy task. Despite there being...

By SEC Newsroom August 23rd, 2022
Clinical & Medical
Four biotech innovators transforming mental health care
A mental health crisis has sparked innovation from major names within the biotechnology indu...

By SEC Newsroom August 22nd, 2022
Clinical & Medical
The rise of virtual clinical trials and why they are here to stay
The COVID-19 pandemic has drastically derailed onsite clinical trials worldwide, leaving las...

By SEC Newsroom June 28th, 2022